InsiderClue
Insiders · Profile

PARMAR KUSH

Director at Entrada Therapeutics · Director at Rallybio · Director at Vor Biopharma · and 1 more. Filing since 16 Nov 2018. CIK 0001664281

TRDA Entrada Therapeutics, Inc. Director · 11 trades RLYB Rallybio Corp Director · 5 trades VOR Vor Biopharma Inc. Director · 2 trades FIXX Q32 Bio Inc. Director · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TRDA Entrada Therapeutics, Inc.
10 Aug 2026
Director
Sold at will
92,444
$647.11K
3.3%
TRDA Entrada Therapeutics, Inc.
7 Aug 2026
Director
Sold at will
52,317
$358.37K
1.8%
TRDA Entrada Therapeutics, Inc.
6 Aug 2026
Director
Sold at will
10,494
$73.46K
0.4%
TRDA Entrada Therapeutics, Inc.
31 Jul 2026
Director
Sold at will
1,718
$11.77K
0.1%
TRDA Entrada Therapeutics, Inc.
30 Jul 2026
Director
Sold at will
114,756
$795.26K
3.9%
TRDA Entrada Therapeutics, Inc.
14 Nov 2025
Director
Sold at will
200,000
$1.76M
6.3%
TRDA Entrada Therapeutics, Inc.
9 Jul 2025
Director
Sold at will
27,000
$202.55K
2.4%
TRDA Entrada Therapeutics, Inc.
1 Jul 2025
Director
Sold at will
25,000
$178.07K
2.2%
TRDA Entrada Therapeutics, Inc.
30 Jun 2025
Director
Sold at will
25,000
$170.32K
2.2%
TRDA Entrada Therapeutics, Inc.
27 Jun 2025
Director
Sold at will
75,000
$518.25K
6.3%
RLYB Rallybio Corp
7 Mar 2023
Director
Sold, plan not stated
100,000
$820.00K
4.0%
RLYB Rallybio Corp
3 Jun 2022
Director
Sold, plan not stated
150,000
$1.88M
10.7%
RLYB Rallybio Corp
23 May 2022
Director
Sold, plan not stated
100,000
$1.30M
7.1%
RLYB Rallybio Corp
8 Feb 2022
Director
Sold, plan not stated
210,000
$2.74M
13.6%
VOR Vor Biopharma Inc.
16 Nov 2021
Director
Sold, plan not stated
330,706
$5.06M
15.8%
TRDA Entrada Therapeutics, Inc.
2 Nov 2021
Director
Bought
250,000
$5.00M
28.3%
RLYB Rallybio Corp
2 Aug 2021
Director
Bought
615,384
$8.00M
77.8%
VOR Vor Biopharma Inc.
9 Feb 2021
Director
Bought
555,555
$10.00M
13.0%
FIXX Q32 Bio Inc.
22 Dec 2020
Director
Sold, plan not stated
500,000
$6.41M
73.4%
FIXX Q32 Bio Inc.
14 Dec 2020
Director
Sold, plan not stated
500,000
$6.13M
71.3%
FIXX Q32 Bio Inc.
16 May 2019
Director
Sold, plan not stated
615,000
$13.20M
73.5%
FIXX Q32 Bio Inc.
10 Dec 2018
Director
Sold, plan not stated
15,575
$405.03K
6.0%
FIXX Q32 Bio Inc.
23 Nov 2018
Director
Sold, plan not stated
29,682
$594.71K
10.7%
FIXX Q32 Bio Inc.
16 Nov 2018
Director
Sold, plan not stated
525,900
$10.62M
68.0%
24 decisions on file.